Oral and vulvovaginal changes in pregnancy

被引:14
作者
Ramos-e-Silva, Marcia [1 ,2 ,3 ]
Martins, Natalia Regina [1 ,2 ,3 ]
Kroumpouzos, George [4 ]
机构
[1] Univ Fed Rio de Janeiro, Univ Hosp, Dermatol Sect, Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Univ Hosp, Postgrad Course, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Sch Med, Rio De Janeiro, Brazil
[4] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, Providence, RI 02912 USA
关键词
HUMAN-PAPILLOMAVIRUS; BEHCETS-DISEASE; RETROSPECTIVE ANALYSIS; INFECTION; TRANSMISSION; PEMPHIGUS; DELIVERY; OUTCOMES; REGISTRY; VACCINE;
D O I
10.1016/j.clindermatol.2016.02.007
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Physiologic alterations of the oral and vulvovaginal mucosal surfaces result from the profound hormonal and immunologic changes of gestation. High estrogen levels are responsible for the vascular changes noted on mucosal surfaces. Gingival hyperemia and edema, gingivitis and pyogenic granuloma are the most common alterations of the oral mucosa during gestation. Physiologic changes of the vulvovaginal area are mainly of vascular nature, and include among others varicose veins. The oral and vulvovaginal mucosal surfaces can be affected by diseases that can worsen or develop in pregnancy. Oral lesions are encountered in a large spectrum of diseases including aphthosis, pemphigus vulgaris, systemic lupus, and Behcet disease. Pregnancy dermatoses such as impetigo herpetiformis and gestational pemphigoid can exceptionally affect the oral mucosa. Infections of the vulvovaginal region by Candida species, Trichomononas vaginalis, human papilloma virus, and herpes simplex virus have been associated with fetal risks. The dermatologist, obstetric medicine physician, and neonatologist should be familiar with the above physiologic changes as well as maternal/fetal risks relevant to disease affecting these mucosal surfaces during gestation. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:353 / 358
页数:6
相关论文
共 38 条
[1]   Vulvovaginal Candidiasis in Pregnancy [J].
Aguin, T. J. ;
Sobel, J. D. .
CURRENT INFECTIOUS DISEASE REPORTS, 2015, 17 (06)
[2]  
[Anonymous], 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000225
[3]   EEMCO guidance for the measurement of skin microcirculation [J].
Berardesca, E ;
Lévêque, JL ;
Masson, P .
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2002, 15 (06) :442-456
[4]   Genital herpes complicating pregnancy [J].
Brown, ZA ;
Gardella, C ;
Wald, A ;
Morrow, RA ;
Corey, L .
OBSTETRICS AND GYNECOLOGY, 2005, 106 (04) :845-856
[5]   Effect of serologic status and Cesarean delivery on transmission rates of herpes simplex virus from-mother to infant [J].
Brown, ZA ;
Wald, A ;
Morrow, RA ;
Selke, S ;
Zeh, J ;
Corey, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (02) :203-209
[6]   Trichomonas vaginalis associated with low birth weight and preterm delivery [J].
Cotch, MF ;
Pastorek, JG ;
Nugent, RP ;
Hillier, SL ;
Gibbs, RS ;
Martin, DH ;
Eschenbach, DA ;
Edelman, R ;
Carey, JC ;
Regan, JA ;
Krohn, MA ;
Klebanoff, MA ;
Rao, AV ;
Rhoads, GG ;
Yaffe, SJ ;
Catz, CS ;
McNellis, D ;
Berendes, HW ;
Blackwelder, WC ;
Kaslow, RA ;
Reed, GF ;
Greenberg, EM ;
Williams, S ;
Rettig, PJ .
SEXUALLY TRANSMITTED DISEASES, 1997, 24 (06) :353-360
[7]   Pregnancy Outcomes From the Pregnancy Registry of a Human Papillomavirus Type 6/11/16/18 Vaccine [J].
Dana, Adrian ;
Buchanan, Karyn M. ;
Goss, Mary Ann ;
Seminack, Margaret M. ;
Shields, Kristine E. ;
Korn, Scott ;
Cunningham, Michael L. ;
Haupt, Richard M. .
OBSTETRICS AND GYNECOLOGY, 2009, 114 (06) :1170-1178
[8]  
Fardiazar Z, 2012, Pak J Biol Sci, V15, P399, DOI 10.3923/pjbs.2012.399.402
[9]  
Ferris G M, 1993, Compendium, V14, P1558
[10]   Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine [J].
Goss, Mary Ann ;
Lievano, Fabio ;
Buchanan, Karyn M. ;
Seminack, Margaret M. ;
Cunningham, Michael L. ;
Dana, Adrian .
VACCINE, 2015, 33 (29) :3422-3428